A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 70 shares of GKOS stock, worth $11,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Holding current value
$11,015
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$126.42 - $152.67 $8,849 - $10,686
70 New
70 $10,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.49B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Fuller & Thaler Asset Management, Inc. Portfolio

Follow Fuller & Thaler Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.